Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from ETHZilla Corporation ( (ETHZ) ).
On September 22, 2025, ETHZilla Corporation announced a $350 million convertible debenture investment with an institutional partner, amending the terms of a previous $156.5 million debenture. The new debentures bear a 2% interest rate and are secured by $50 million in Ether and $500 million in cash. The company also updated its stock repurchase program, having repurchased approximately 0.5 million shares at an average price of $2.41 per share. ETHZilla continues to focus on deploying capital across the Ethereum ecosystem, with a current ETH position valued at approximately $462 million as of September 19, 2025. The company is committed to transparency in its financial strategies and aims to provide further guidance in its Q3 earnings release.
More about ETHZilla Corporation
ETHZilla Corporation, formerly known as 180 Life Sciences Corp, operates in the decentralized finance (DeFi) technology sector. The company focuses on deploying Ethereum (ETH) into cash-flowing assets and tokenizing real-world assets to generate free cash flow on the Ethereum network. ETHZilla aims to build its capital reserves and support a diverse range of protocols within the Ethereum ecosystem.
Average Trading Volume: 13,765,486
Technical Sentiment Signal: Sell
Current Market Cap: $416.1M
Learn more about ETHZ stock on TipRanks’ Stock Analysis page.